Bifidobacterium bifidum R0071
Natural health product licensed in Canada
- Licence holder
- Lallemand Health Solutions (Institut Rosell)
- NPN or DIN-HM
- 80063177
- Status
- Active licence
- Licence date
- 6 August 2015
- Revision date
- 7 July 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium bifidum Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Saccharose, Stéarate de magnésium, Hypromellose, Fécule de pommes de terre, Acide ascorbique, Extrait de Levure, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants (1 an et plus), adolescents et adultes | minimum: 1 year | 1 Capsule | 1 Tous les jours |
| Nourrissons | maximum: 1 year | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps support intestinal/gastrointestinal health. Could promote favorable gut flora. Source of probiotics. Helps reduce the incidence of cold-like symptoms in stressed adults. Helps to maintain a baby-like microflora in infants (for formula fed infants). Helps to balance formula fed baby¿s microflora similar to breast-fed infants
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use . If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. This product has been in contact with soy and milk. If you have milk or soy allergy, do not use this product.
Source
Official Health Canada record, licence 80063177
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging